Sample size determination for fold-increase endpoints defined by paired interval-censored data

References

• Chen, M. I., Lee, V. J., Lim, W. Y., Barr, I. G., Lin, R. T., Koh, G. C., Yap, J., Cui, L., Cook, A. R., Laurie, K., Tan, L. W., Tan, B. H., Loh, J., Shaw, R., Durrant, C., Chow, V. T., Kelso, A., Chia, K. S., Leo, Y. S. (2010). 2009 influenza A (H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA 303:1383–1391.
   PubMed Web of Science ®Google Scholar
• Dudareva, S., Schweiger, B., Thamm, M., Höhle, M., Stark, K., Krause, G., Buda, S., Haas, W. (2011). Prevalence of antibodies to 2009 pandemic influenza A (H1N1) virus in German adult population in pre- and post-pandemic period. PLoS One 6:e21340.
   Google Scholar
• Feiveson, A. H. (2002). Power by simulation. The Stata Journal 2:107–124.
   Web of Science ®Google Scholar
• Fleiss, J. L., Levin, B., Paik, M. C. (2003). Statistical Methods for Rates and Proportions. 3rd edition. New York: Wiley.
   Google Scholar
• Liu, G. F., Lu, K., Mogg, R., Mallick, M., Mehrotra, D. V. (2009). Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials? Statistics in Medicine 28:2509–2530.
   PubMed Web of Science ®Google Scholar
• Liang K. Y., Zeger S. (2000). Longitudinal data analysis of continuous and discrete responses for pre–post designs. Sankhyā: The Indian Journal of Statistics (Series B) 62:134–148.
   Google Scholar
• Food and Drug Administration. (2007). Guidance for Industry: Clinical Data Needed to Support the Licensure of Pandemic Influenza Vaccines. US Food and Drug Administration, Rockville, MD.
   Google Scholar
• Frison, L., Pocock, S. J. (1992). Repeated measures in clinical trials: Analysis using mean summary statistics and its implications for design. Statistics in Medicine 11:1685–1704.
   PubMed Web of Science ®Google Scholar
• Heitjan, D. F. (1991). Regression with bivariate grouped data. Biometrics 47:549–562.
   PubMed Web of Science ®Google Scholar
• Hughes, M. D. (2000). Analysis and design issues for studies using censored biomarker measurements with an example of viral load measurements in HIV clinical trials. Statistics in Medicine 19:3171–3191.
   PubMed Web of Science ®Google Scholar
• Laird, N. M., Ware, J. H. (1982). Random-effects models for longitudinal data. Biometrics 38:963–974.
   PubMed Web of Science ®Google Scholar
• Lara, P. N. Jr., Paterniti, D. A., Chiechi, C., Turrell, C., Morain, C., Horan, N., Montell, L., Gonzalez, J., Davis, S., Umutyan, A., Martel, C. L., Gandara, D. R., Wun, T., Beckett, L. A., Chen, M. S. Jr. (2005). Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. Journal of Clinical Oncology 23:9282–9289.
   PubMed Web of Science ®Google Scholar
• Liu, G., Liang, K. Y. (1997). Sample size calculations for studies with correlated observations. Biometrics 53:937–947.
   PubMed Web of Science ®Google Scholar
• Louis, T. A. (1982). Finding the observed information matrix when using the EM algorithm. Journal of the Royal Statistical Society, Series B 44:226–233.
   Web of Science ®Google Scholar
• Muthén, B. (1990). Moments of the censored and truncated bivariate normal distribution. British Journal of Mathematical and Statistical Psychology 43:131–143.
   Web of Science ®Google Scholar
• Nauta, J. (2006). Eliminating bias in the estimation of the geometric mean of HI titres. Biologicals 34:183–186.
   PubMed Web of Science ®Google Scholar
• Nauta, J. J., de Bruijn, I. A. (2006). On the bias in HI titers and how to reduce it. Vaccine 24:6645–6646.
   PubMed Web of Science ®Google Scholar
• Nauta, J. (2007). Reply to Letter to the Editor on “Eliminating bias in the estimation of the geometric mean of HI titres” [ Biologicals 2006;34(3):183–6]. Biologicals 35:153.
   Web of Science ®Google Scholar
• Nauta, J. (2010). Statistics in Clinical Vaccine Trials. New York: Springer.
   Google Scholar
• Orchard, T., Woodbury, M. A. (1972). A Missing Information Principle: Theory and Applications. Proceedings of the Sixth Berkeley Symposium on Mathematical Statistics and Probability 1:697–715.
   Google Scholar
• Paton, N., Lee, L., Xu, Y., Ooi, E. E., Cheung, Y. B., Archuleta, S., Wong, G., Wilder-Smith A. (2011). The CHloroquine for Influenza Prevention (CHIP) Trial: a randomised, double-blind, placebo controlled trial of chloroquine for the prevention of influenza. The Lancet Infectious Diseases 11:677–683.
   PubMed Web of Science ®Google Scholar
• Peacock, J. L., Sauzet, O., Ewings, S. M., Kerry, S. M. (2012). Dichotomizing continuous data while retaining statistical power using a distributional approach. Statistics in Medicine 31:3089–3103.
   PubMed Web of Science ®Google Scholar
• Rao, C. R. (1973). Linear Statistical Inference and Its Applications. 2nd edition. New York: John Wiley & Sons Inc.
   Google Scholar
• Suissa, S. (1991). Binary methods for continuous outcomes: a parametric alternative. Journal of Clinical Epidemiology 44:241–248.
   PubMed Web of Science ®Google Scholar
• Verbeke, G., Molenberghs, G. (2000). Linear Mixed Models for Longitudinal Data. New York: Springer.
   Google Scholar
• Xu, Y., Lam, K. F., Ooi, E. E., Wilder-Smith, A., Paton, N. I., Lee, S. L., Cheung, Y. B. (2015). A simple and powerful method for the estimation of intervention effects on serological endpoints using paired interval censored data. Journal of Biopharmaceutical Statistics 25:124–136.
   PubMed Web of Science ®Google Scholar